Aclaris Therapeutics Appoints Jesse Hall As CMO
(RTTNews) - Aclaris Therapeutics, Inc. (ACRS), a clinical-stage biopharmaceutical company, on Tuesday announced the appointment of Jesse Hall as Chief Medical Officer. The transition is effective May 1.
Hall has decades of experience in all phases of drug development. Hall most recently worked as Chief Medical Officer at AltruBio.
On Monday, Aclaris had closed 1.49% higher at $1.36 on the Nasdaq.
Founded in the late 1990s by Andrew Mariathasan in New York, with the goal of covering Wall Street for a new generation of investors, RTTNews has expanded steadily over the years to become a trusted provider of content for a wide array of subjects across several platforms. RTT's Financial Newswire is relied upon by some of the world's largest financial institutions, including banks, brokerages, trading platforms and financial exchanges.